Features Screener Stocks Charts
Sign In Sign Up

Glaxosmithkline Pharmaceuticals Ltd. Income Statement

NSE:GLAXO | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year GLAXO income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 35.76B 38.95B
Cost of Revenue -13.35B -13.91B
Gross Profit 22.42B 25.04B
Sales, General & Admin -12.10B -11.81B
Operating Income 9.62B 12.57B
Profit Before Tax 8.16B 12.60B
Net Income 5.90B 9.28B
Diluted Shares 169.38M 169.39M
Diluted EPS 34.83 54.76

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025